Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, W.K. Roentgen 5, 02-781, Warsaw, Poland.
Department of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
Sci Rep. 2020 Sep 3;10(1):14610. doi: 10.1038/s41598-020-71579-6.
Available epidemiological reports on follicular lymphoma (FL) often highlight a significant discrepancy between its high and low incidence rates in Western and Eastern Europe, respectively. The reasons behind that difference are not fully understood, but underreporting is typically presumed as one of the main factors. This study aimed to assess FL epidemiology in Poland based on 2000-2014 data from the Polish National Cancer Registry, which has 100% population coverage and over 90% completeness of the registration. All cases were coded according to ICD-10 and ICD-O-3 recommendations. The total number of registered FL cases was 3,928 with crude (CR) and standardized (SR) incidence rates of 0.72/10 and 0.87/10, respectively. The median age of FL diagnosis was 61 years, with the male to female incidence ratio of 1.06. The distribution of morphological types of FL: not otherwise specified (NOS), grades 1, 2, or 3 were 72.58, 4.81, 12.88, and 9.73%, respectively. Among all reported mature B-cell non-Hodgkin lymphomas, FL was ranked the fourth in incidence, just after chronic lymphocytic leukemia/small lymphocytic lymphoma (CR 3.62/10, SR 4.99/10), plasma cell neoplasms (CR 3.78/10, SR 4.97/10) and diffuse B-cell lymphoma, NOS (CR 2.13/10, SR 2.65/10). The systematic increase in FL incidence among females was observed. Our study confirms a lower FL incidence rate in Poland as compared to other European countries. Moreover, as our analysis was based on a registry with high data completeness, it provides evidence that reasons other than underreporting are responsible for FL incidence discrepancies between Eastern and Western Europe.
有关滤泡性淋巴瘤(FL)的现有流行病学报告经常强调,其在西欧和东欧的发病率高低之间存在显著差异。造成这种差异的原因尚不完全清楚,但通常认为漏报是主要因素之一。本研究旨在根据波兰国家癌症登记处 2000-2014 年的数据评估波兰的 FL 流行病学情况,该登记处的人口覆盖率为 100%,登记的完整性超过 90%。所有病例均根据 ICD-10 和 ICD-O-3 建议进行编码。共登记滤泡性淋巴瘤病例 3928 例,粗发病率(CR)和标准化发病率(SR)分别为 0.72/10 和 0.87/10。FL 诊断的中位年龄为 61 岁,男女发病率比为 1.06。FL 的形态学类型分布:非特指型(NOS)、1 级、2 级或 3 级分别为 72.58%、4.81%、12.88%和 9.73%。在所有报告的成熟 B 细胞非霍奇金淋巴瘤中,FL 的发病率排名第四,仅次于慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CR 3.62/10,SR 4.99/10)、浆细胞瘤(CR 3.78/10,SR 4.97/10)和弥漫性 B 细胞淋巴瘤,NOS(CR 2.13/10,SR 2.65/10)。女性中滤泡性淋巴瘤的发病率呈系统上升。本研究证实波兰的 FL 发病率低于其他欧洲国家。此外,由于我们的分析基于数据完整性较高的登记处,因此它提供了证据,表明除漏报外,其他原因也导致了东欧和西欧之间 FL 发病率的差异。
Epidemiol Prev. 2016
Clin Lymphoma Myeloma Leuk. 2017-9
Epidemiol Prev. 2013
Br J Ophthalmol. 2020-8